Connect with us

Business

US FDA grants emergency use authorization to Regeneron COVID-19 antibody given to Trump – Fox Business

The company said it expects to have does of REGEN-COV2 treatment ready for about 80,000 patients by the end of this month

Published

on

post featured image
ADVERTISEMENT

The U.S. Food and Drug Administration on Saturday issued emergency use authorization for Regeneron Pharmaceuticals Inc’s COVID-19 antibody therapy, an experimental treatment given to U.S. President Donald Trump that he said helped cure him of the disease.
The FDA said the monoclonal antibodies, casirivimab and imdevimab, should be administered together for the treatment of mild to moderate COVID-19 in adults and pediatric patients with positive results of direct SARS-CoV-2 viral testing and who…

Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

post featured image
Bitcoin price plunges over 10% to stage Thanksgiving correction – MarketWatch
Astra Likely to Run Fresh Global Vaccine Trial, CEO Says – Bloomberg
post featured image
Hulu Black Friday Deal: Get 1 Year for $1.99 a Month – IGN – IGN